What Happened?
Cambridge, MA-based Marengo-Therapeutics Appointed Ke Liu as Chief Development Officer
About the Company
Marengo Therapeutics is pioneering an entirely new way to activate the body`s own immune system to mount a rapid, effective, and durable response against cancer. Our unique therapeutic platform selectively boosts T cells, turbocharging potent anti-tumor activity and promoting long-term immunity to keep cancer at bay.
About the Person
Ke Liu is Chief Development Officer at Marengo Therapeutics. Previously, Ke held various senior HR leadership roles in the industry.
Info Source
News
Short Profile